Li, Nanxin <br/><br/>
Comparison of medical costs and healthcare resource utilization of post-menopausal women with HR+/HER2- metastatic breast cancer receiving everolimus-based therapy or chemotherapy: a retrospective claims database analysis.  [electronic resource] 

 -  Journal of medical economics  2016 
 - 414-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1941-837X 
<br/><br/><label>Standard No.: </label>10.3111/13696998.2015.1131704  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--economics<br/>Antineoplastic Combined Chemotherapy Protocols--economics<br/>Breast Neoplasms--drug therapy<br/>Everolimus--economics<br/>Female<br/>Health Expenditures--statistics & numerical data<br/>Health Services--economics<br/>Humans<br/>Insurance Claim Review--statistics & numerical data<br/>Kaplan-Meier Estimate<br/>Neoplasm Metastasis<br/>Receptor, ErbB-2<br/>Retrospective Studies